{"id":"https://openalex.org/W1974101822","doi":"https://doi.org/10.1097/00019616-200010020-00002","title":"Apo B and Lp(a)","display_name":"Apo B and Lp(a)","publication_year":2000,"publication_date":"2000-03-01","ids":{"openalex":"https://openalex.org/W1974101822","doi":"https://doi.org/10.1097/00019616-200010020-00002","mag":"1974101822"},"language":"en","primary_location":{"id":"doi:10.1097/00019616-200010020-00002","doi":"https://doi.org/10.1097/00019616-200010020-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00019616-200010020-00002","pdf_url":null,"source":{"id":"https://openalex.org/S62916020","display_name":"The Endocrinologist","issn_l":"1051-2144","issn":["1051-2144","1539-9192"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Endocrinologist","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085486302","display_name":"Randy Linde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1317822957","display_name":"Palo Alto Medical Foundation","ror":"https://ror.org/04rg6e566","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I114073160","https://openalex.org/I1317822957"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Randy Linde","raw_affiliation_strings":["Randy Linde, M.D., Division of Endocrinology, Palo Alto Medical Foundation, Palo Alto, CA 94301. Phone: 650-329-8971","The author discloses: Member of speaker's bureau of Pfizer and Parke-Davis. Unapproved/investigational uses of drugs or devices are discussed in this CME review article"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Randy Linde, M.D., Division of Endocrinology, Palo Alto Medical Foundation, Palo Alto, CA 94301. Phone: 650-329-8971","institution_ids":["https://openalex.org/I1317822957"]},{"raw_affiliation_string":"The author discloses: Member of speaker's bureau of Pfizer and Parke-Davis. Unapproved/investigational uses of drugs or devices are discussed in this CME review article","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5085486302"],"corresponding_institution_ids":["https://openalex.org/I1317822957"],"apc_list":null,"apc_paid":null,"fwci":0.242,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.59709463,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"2","first_page":"83","last_page":"89"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":1.0},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8379999995231628},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8790000081062317},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/treatment-eligibility","display_name":"treatment eligibility","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9009547829627991},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.8003429174423218},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.6884187459945679},{"id":"https://openalex.org/C2776104379","wikidata":"https://www.wikidata.org/wiki/Q21112670","display_name":"Lipoprotein(a)","level":4,"score":0.6757020950317383},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6215547919273376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48313090205192566},{"id":"https://openalex.org/C2779120738","wikidata":"https://www.wikidata.org/wiki/Q2711291","display_name":"Familial hypercholesterolemia","level":3,"score":0.44909390807151794},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4419702887535095},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4156595766544342},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/00019616-200010020-00002","doi":"https://doi.org/10.1097/00019616-200010020-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00019616-200010020-00002","pdf_url":null,"source":{"id":"https://openalex.org/S62916020","display_name":"The Endocrinologist","issn_l":"1051-2144","issn":["1051-2144","1539-9192"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Endocrinologist","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1027212289","https://openalex.org/W2523206465","https://openalex.org/W4402280397","https://openalex.org/W2437782629","https://openalex.org/W4401599833","https://openalex.org/W2043468594","https://openalex.org/W4392360387","https://openalex.org/W2139178775","https://openalex.org/W2107424758","https://openalex.org/W2788580632"],"abstract_inverted_index":{"Disorders":[0],"of":[1,15,30,50,96,100,113,157,169,182,190],"lipoprotein":[2,140,184],"metabolism":[3],"are":[4,7,151],"common":[5],"and":[6,27,62,65,102,130,162,174,193],"thought":[8],"to":[9,55,122],"account":[10],"for":[11,91],"at":[12],"least":[13],"50%":[14],"all":[16],"cardiac":[17,45],"risk.":[18,46,117],"Significant":[19],"advances":[20],"have":[21,35],"been":[22],"made":[23],"in":[24,132,187],"the":[25,74,94,166,179,188],"dietary":[26],"pharmacologic":[28],"treatment":[29,92],"dyslipidemic":[31],"states.":[32],"Outcome":[33],"studies":[34],"shown":[36],"that":[37,59],"medications,":[38],"especially":[39],"hydroxymethylglutarylCoA":[40],"reductase":[41],"inhibitors,":[42],"substantially":[43],"lower":[44],"Yet":[47],"a":[48],"majority":[49],"patients":[51,78,133],"do":[52,88],"not":[53,89],"appear":[54],"benefit":[56,83],"from":[57,84,138],"medication":[58],"adds":[60],"expense":[61],"potential":[63],"morbidity":[64],"generally":[66],"is":[67,120,136,178],"prescribed":[68],"on":[69,93],"an":[70,114],"indefinite":[71],"basis.":[72],"On":[73],"other":[75],"hand,":[76],"some":[77],"with":[79],"dyslipidemias":[80],"would":[81],"theoretically":[82],"drug":[85],"therapy,":[86],"but":[87],"qualify":[90],"basis":[95],"national":[97],"guidelines.":[98],"Fractionation":[99],"HDL":[101],"LDL":[103],"cholesterol,":[104],"begun":[105],"two":[106],"decades":[107],"ago,":[108],"has":[109],"improved":[110],"clinicians'":[111],"understanding":[112,125],"individual":[115],"patient's":[116],"Now":[118],"it":[119],"time":[121],"extend":[123],"this":[124],"by":[126,153],"measuring":[127,154],"apolipoprotein":[128,158],"B":[129,159,173,192],"lipoprotein(a)":[131,163],"whose":[134],"risk":[135],"unclear":[137],"standard":[139],"values.":[141],"The":[142],"Endocrinologist":[143],"2000;":[144],"10:":[145],"83-89":[146],"Learning":[147],"Objectives:":[148],"What":[149,177],"purposes":[150],"served":[152],"blood":[155],"levels":[156],"(Apo":[160],"B)":[161],"[Lp(a)]?":[164],"Review":[165],"diagnostic":[167],"implications":[168],"abnormally":[170],"elevated":[171],"Apo":[172,191],"Lp(a)":[175,194],"concentrations.":[176],"current":[180],"role":[181],"low-density":[183],"(LDL)":[185],"electrophoresis":[186],"context":[189],"estimates?":[195]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2016-06-24T00:00:00"}